Mutually exclusive recurrent KRAS and MAP2K1 mutations in Rosai–Dorfman disease
Modern Pathology2017Vol. 30(10), pp. 1367–1377
Citations Over TimeTop 1% of 2017 papers
Sofía Garcés, L. Jeffrey Medeiros, Keyur P. Patel, Shaoying Li, Sergio Piña‐Oviedo, Jingyi Li, Juan Carlos Garcés, Joseph D. Khoury, C. Cameron Yin
Related Papers
- → Mutation analysis of the Ras pathway genes NRAS, HRAS, KRAS and BRAF in glioblastomas(2004)160 cited
- → Drugging All RAS Isoforms With One Pocket(2020)73 cited
- → Frequency of RAS Mutations (KRAS, NRAS, HRAS) in Human Solid Cancer(2017)51 cited
- → Ras Mutations in Cancer(2013)4 cited
- → The landscape of RAS mutations and hotspots in Chinese patients with solid tumors.(2022)